ORIGINAL ARTICLESEffects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
References (35)
- et al.
Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis
Lancet
(1983) - et al.
Can lifestyle changes reverse coronary heart disease?
Lancet
(1990) - et al.
Primary prevention of atherosclerosis by lovastatin in a genetically hyperlipidaemic rabbit strain
Atherosclerosis
(1989) - et al.
Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake
Lancet
(1981) - et al.
A multifactorial diet in the management of hyperlipidaemia
Atherosclerosis
(1984) - et al.
Angiographic progression of coronary artery disease and the development of myocardial infarction
J Am Coll Cardiol
(1988) - et al.
Coronary stenoses before and after acute myocardial infarction
Am J Cardiol
(1989) The treatment of hyperlipidaemia in adults. Recommendations of the European Atherosclerosis Society
Eur Heart J
(1988)- et al.
Diet, lipoproteins, and the progression of coronary atherosclerosis
N Engl J Med
(1985) - et al.
The influence of diet on the appearance of new lesions in human coronary arteries
JAMA
(1990)
Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population
Br Med J
(1974)
Grading of angina pectoris
Circulation
(1976)
AHA committee report. A reporting system on patients evaluated for coronary artery disease
Circulation
(1975)
Measurement of vessel calibre and volume blood flow by dynamic quantitative digital angiography: an initial application showing variation of cerebral artery diameter with PaCO2
J Cerebr Blood Flow Metab
(1983)
Exploitation of computer vision technology in coronary cineangiographic analysis. (Computers in cardiology, 13.)
(1987)
Arteriographic assessment of coronary atherosclerosis
Arteriosclerosis
(1982)
Cited by (755)
Lipid clinical trials with special reference to Indian population
2024, Indian Heart JournalEffect of dietary fatty acid intake on cardiovascular disease
2023, Functional Dietary Lipids: Food Formulation, Consumer Issues, and Innovation for Health, Second EditionBile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases
2022, Acta Pharmaceutica Sinica BCitation Excerpt :BA sequestrants, including colesevelam, colestimide, cholestyramine, and colestipol, have beneficial effects on lipid metabolism, glycemic control and insulin sensitivity in AS and diabetic rodents125,126. Cholestyramine is well tolerated and to exert cholesterol-lowering effects as well as to reduce CVD mortality127,128. A randomized clinical trial demonstrated that together with a fat-modified diet, cholestyramine could improve the course of CVD in men with phenotypic familial hypercholesterolaemia129.
Copyright © 1992 Published by Elsevier Ltd.